Problems in the diagnosis of fragile X syndrome in young children are still present

Area of Science:

• Genetics
• Pediatrics
• Neurology

Background:

• Fragile X syndrome (FXS) is the most prevalent inherited cause of intellectual disability, affecting approximately 1 in 5,000 individuals.
• Despite available diagnostic information, timely diagnosis remains a challenge for healthcare professionals.
• FXS diagnosis requires a comprehensive approach considering genetic, clinical, and developmental factors.

Observation:

• This study examines diagnostic challenges in 11 young children (10 boys, 1 girl) with Fragile X syndrome.
• Initial symptoms were nonspecific, including macrocephaly, overgrowth, and obesity, often leading to unremarkable physical examinations.
• Delayed diagnosis was attributed to nonspecific clinical features, seemingly noncontributory family histories, and postponed molecular genetic testing.

Findings:

• Nonspecific clinical presentations and delayed molecular testing significantly contribute to diagnostic delays in Fragile X syndrome.
• Early and accurate diagnosis is crucial for effective management and intervention in affected children.
• The study underscores the importance of considering FXS in young children presenting with subtle or nonspecific developmental and behavioral concerns.

Implications:

• Enhanced education for medical and allied health professionals on Fragile X syndrome recognition is essential.
• Routine molecular screening should be considered in cases of suspected FXS, even with seemingly unremarkable initial evaluations.
• Improved diagnostic pathways can lead to earlier intervention, optimizing developmental outcomes for individuals with Fragile X syndrome.